Spruce Biosciences
BiopharmaSouth San Francisco, California, United StatesPost-IPO Equity$271.6M total fundingwww.sprucebiosciences.com
Latest funding:$60.0M · Post-IPO Equity (April 20, 2026)
Angel investors who backed Spruce Biosciences
27 investors in our database backed Spruce Biosciences.
Michelle Doig
Board Observer
Katie Kerfoot
Vice President
Paulina Hill
Principal
Otello Stampacchia
Managing Director
Bali Muralidhar
Managing Partner, Chief Investment Officer
Kurt von Emster
Board Member
andrew sinclair
Managing Director
Vin Miles
Executive Director
Genghis Lloyd-Harris
Senior Advisor
John Heard
General Counsel
Tim Haines
Chairman and Managing Partner
Chris Jackson
MBA Candidate
Staffan Lindstrand
Partner
Johan Christenson
Partner
Anki Forsberg
Partner
Nikki Matthews
Senior Vice President
Keith Underwood
Senior Vice President
Jason Dodd
Board Member
Karen Spilizewski
Managing Director
Derek Rapp
Managing Director
Niall O`Donnell
Managing Director
Michael Berman
General Dentist
Jay Schmelter
Co-Founder and Managing Director
John McKearn
Managing Director
Sivan Weitzman
CFO
Curtis Rother
Senior Analyst
Tom Melzer
Co-founder, Managing Director
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Spruce Biosciences.
Search investors